100 Million Gallery
At StarFish Medical, our 100×100 vision reflects a simple but powerful commitment.
We aim to help 100 of our clients grow into companies worth more than $100 million by focusing on what matters most: creating products with true clinical impact. It’s about designing medical technologies that deliver long-term value for patients, providers, and innovators. The 100×100 wall recognizes the bold ideas, transformative breakthroughs, and enduring partnerships that make this vision real.
Misonix partnered with StarFish Medical to support the development of the Nexus ultrasonic surgical platform.
Delivered a production ready wearable insulin pump and collaborated closely with MiniMed’s internal team to support design transfer.
StarFish Medical partnered with Inogen to help develop the the first portable oxygen concentrator, handling industrial design, mechanical engineering, and the creation of functional prototypes.
Novadaq engaged StarFish Medical to design, prototype and develop the mechanical system for their first product, the SPY3000 imaging system.
Hemosonics developed a standalone point of care global hemostasis analysis device to provide rapid, easy to interpret assessment of overall hemostatic potential in a variety of clinical settings.
Thermo-Acoustic Enhanced Ultrasound® (TAEUS®) combines radio frequency and ultrasound waves to measure fat in the liver in a groundbreaking way.
Home Dialysis Plus (HD+) engaged StarFish Medical to develop and prototype their novel haemodialysis system aimed at the home market.
In 2012, MicroPharma began developing diagnostic and therapeutic technology platforms spearheaded by ingestible devices.
Light Matter Interaction Inc. developed a proof of concept of a pico-second near-infrared laser cataract surgery instrument.
LensGen is developing an accommodative intraocular lens (AIOL) for the treatment of presbyopia.
Perimeter engaged StarFish in 2014 to develop an Optical Coherence Tomography (OCT) imaging device for use during surgical procedures.